Calithera Biosciences, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calithera Biosciences, Inc. has filed 530 SEC EDGAR filings since 16 Jul 2010

SEC filing history

Showing 301-325 of 530 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
22 Feb 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

SC 13G/A filing

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

SC 13G/A

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

CALITHERA BIOSCIENCES, INC.

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

SEC SCHEDULE 13G

Filing date
08 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

SEC SCHEDULE 13G

Filing date
08 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88349

SC 13G filing

Filing date
01 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

8-K

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2017
Reporting date
05 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Dec 2017
Reporting date
05 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

8-K

Filing date
02 Nov 2017
Reporting date
02 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

CALITHERA BIOSCIENCES, INC.

Filing date
28 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

ADAGE CAPITAL PARTNERS, GP L.L.C.

Filing date
28 Sep 2017
Reporting date
26 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
21 Sep 2017
Reporting date
20 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .